Hanafusa N - Search Results

1

Pioglitazone opposes neurogenic vascular dysfunction associated with chronic hyperinsulinaemia.

Takatori S, Zamami Y, Yabumae N, Hanafusa N, Mio M, Egawa T, Kawasaki H. Takatori S, et al. Among authors: hanafusa n. Br J Pharmacol. 2008 Apr;153(7):1388-98. doi: 10.1038/bjp.2008.8. Epub 2008 Feb 4. Br J Pharmacol. 2008. PMID: 18246090 Free PMC article.

2

Involvement of hypothalamic periventricular GABAergic nerves in the central pressor response to clonidine in freely-moving conscious rats.

Hanafusa N, Okamoto K, Takatori S, Kawasaki H. Hanafusa N, et al. J Pharmacol Sci. 2012;118(3):382-90. doi: 10.1254/jphs.11233fp. J Pharmacol Sci. 2012. PMID: 22450196 Free article.

3

Is the "Nutritional Risk Index for Japanese Hemodialysis" validated as a nutritional and prognostic indicator?

Mori K, Yamamoto Y, Hanafusa N, Yamamoto S, Fukuma S, Onishi Y, Emoto M, Inaba M. Mori K, et al. Among authors: hanafusa n. J Ren Nutr. 2024 Dec 12:S1051-2276(24)00287-5. doi: 10.1053/j.jrn.2024.12.004. Online ahead of print. J Ren Nutr. 2024. PMID: 39674429 No abstract available.

4

Higher Serum Alkaline Phosphatase is Risk for Death and Fracture: A Nationwide Cohort Study of Japanese Dialysis Patients.

Maruyama Y, Nakashima A, Abe M, Hanafusa N, Nakai S, Yokoo T. Maruyama Y, et al. Among authors: hanafusa n. Kidney360. 2024 Nov 26. doi: 10.34067/KID.0000000656. Online ahead of print. Kidney360. 2024. PMID: 39589810 Free article.

5

Lower Parathyroid Hormone Levels are Associated With Reduced Fracture Risk in Japanese Patients on Hemodialysis.

Komaba H, Imaizumi T, Hamano T, Fujii N, Abe M, Hanafusa N, Fukagawa M. Komaba H, et al. Among authors: hanafusa n. Kidney Int Rep. 2024 Jul 18;9(10):2956-2969. doi: 10.1016/j.ekir.2024.07.008. eCollection 2024 Oct. Kidney Int Rep. 2024. PMID: 39430172 Free PMC article.

6

Association of Nutritional Risk Index With Infection-Related Hospitalization and Death After Hospitalization in Patients Undergoing Maintenance Hemodialysis.

Mori K, Yamamoto Y, Hanafusa N, Yamamoto S, Fukuma S, Onishi Y, Emoto M, Inaba M. Mori K, et al. Among authors: hanafusa n. J Ren Nutr. 2024 Jul 29:S1051-2276(24)00170-5. doi: 10.1053/j.jrn.2024.07.017. Online ahead of print. J Ren Nutr. 2024. PMID: 39084324 Free article.

7

Erythropoiesis-stimulating agent hyporesponsiveness was associated with worse survival of hemodialysis patients independent of the serum ferritin level.

Hanafusa N, Henn L, Bieber B, Hasegawa T, Usui T, Robinson B, Karaboyas A, Nangaku M. Hanafusa N, et al. Ther Apher Dial. 2025 Feb;29(1):23-33. doi: 10.1111/1744-9987.14169. Epub 2024 Jul 4. Ther Apher Dial. 2025. PMID: 38962901

8

Association Between Disturbed Serum Phosphorus Levels and QT Interval Prolongation.

Sasaki S, Fujisaki K, Nishimura M, Nakano T, Abe M, Hanafusa N, Joki N. Sasaki S, et al. Among authors: hanafusa n. Kidney Int Rep. 2024 Mar 13;9(6):1792-1801. doi: 10.1016/j.ekir.2024.03.007. eCollection 2024 Jun. Kidney Int Rep. 2024. PMID: 38899225 Free PMC article.

9

Frailty and Duration of Maintenance Dialysis: A Japanese Nationwide Cross-Sectional Study.

Yamamoto S, Niihata K, Toida T, Abe M, Hanafusa N, Kurita N. Yamamoto S, et al. Among authors: hanafusa n. Am J Kidney Dis. 2024 Nov;84(5):601-612.e1. doi: 10.1053/j.ajkd.2024.04.012. Epub 2024 Jun 12. Am J Kidney Dis. 2024. PMID: 38876273

10

Current dialyzer classification in Japan and mortality risk in patients undergoing hemodialysis.

Abe M, Kikuchi K, Wada A, Nakai S, Kanda E, Hanafusa N. Abe M, et al. Among authors: hanafusa n. Sci Rep. 2024 May 4;14(1):10272. doi: 10.1038/s41598-024-60831-y. Sci Rep. 2024. PMID: 38704419 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters